Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Neuberger High Yield Strategies Fund Inc.
Bear Case (25th pct.)
31.8% vs price
Base Case (Median)
43.9% vs price
Bull Case (75th pct.)
134.7% vs price
◇ = Current price | | Bear | Base | Bull
| Method | Est. Value | vs Price | Weight |
|---|---|---|---|
| DCF (Discounted Cash Flow) | $17.82 | 225.8% | High (40%) |
| PE Comparable | $7.87 | 43.8% | Medium (25%) |
| Graham Number | $6.56 | 20.0% | High (80%) |
Based on 3 out of 8 methods, NHS appears undervalued at the current price of $5.47. The base case fair value of $7.87 implies 43.9% upside.
Bear/base/bull cases represent the 25th, 50th, and 75th percentile of available method estimates. This is not financial advice. Valuation is inherently uncertain.